Our study cohort included 6 patients with MPN with germline CHST15 mutations from 3 unique families.There were 5 females and 1 male; the age at disease onset ranged from 28 to 55 years, with a median age of 46.3 years. This evidence concerns the gene CHST15 and myeloproliferative neoplasm.